History | Risankizumab for treating moderate to severe plaque psoriasis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 157 KB)

Published:

21 August 2019

Final draft guidance

Final draft guidance
Final appraisal document (PDF 235 KB)

Published:

12 July 2019
Committee papers (PDF 4.32 MB)

Published:

12 July 2019
Public committee slides (PDF 1.1 MB)

Published:

12 July 2019

Notes

Note

Invitation to participate

Final scope (PDF 273 KB)

Published:

06 November 2018
Final matrix (PDF 257 KB)

Published:

06 November 2018
Equality impact assessment (Scoping) (PDF 177 KB)

Published:

06 November 2018
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 339 KB)

Published:

14 March 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 288 KB)

Published:

06 June 2018
Draft matrix pre referral (PDF 257 KB)

Published:

06 June 2018